These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 430357)

  • 21. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent beneficial hemodynamic effects of BAY 41-2272 in a canine model of acute pulmonary thromboembolism.
    Cau SB; Dias-Junior CA; Montenegro MF; de Nucci G; Antunes E; Tanus-Santos JE
    Eur J Pharmacol; 2008 Feb; 581(1-2):132-7. PubMed ID: 18076875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative heart rate effects of oral administration of bitolterol, terbutaline and trimetoquinol in unanesthetized dogs.
    Nakanishi H; Nakahata N; Ito G; Yoshida H
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):185-8. PubMed ID: 6104851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of salmeterol xinafoate in laboratory animals and humans.
    Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH
    Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some pharmacodynamic effects of eformoterol in the horse.
    Ladaga GJ; Lezica FP; Ferraro G; De Erausquin GA
    J Vet Pharmacol Ther; 2007 Oct; 30(5):496-9. PubMed ID: 17803747
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular and respiratory effects of thiopental administration in hypovolemic dogs.
    Ilkiw JE; Haskins SC; Patz JD
    Am J Vet Res; 1991 Apr; 52(4):576-80. PubMed ID: 2053727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose pharmacokinetics of mabuterol in man.
    Guentert TW; Buskin JN; Galeazzi RL
    Arzneimittelforschung; 1984; 34(11A):1691-6. PubMed ID: 6152164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
    Murai T; Maejima T; Sanai K; Osada E
    Arzneimittelforschung; 1984; 34(11A):1633-40. PubMed ID: 6152156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhalation therapy with selective beta 2-sympathomimetic drugs. Effect of pirbuterol administered via the Autohaler and salbutamol administered via the Diskhaler in obstructive respiratory tract disease].
    Hoffarth HP; Freyberger H; Völkl KP; Ulmer WT
    Fortschr Med; 1990 Mar; 108(8):162-4. PubMed ID: 2186991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of action of bronchodilators].
    Yanaura S; Ishizaki M; Ishikawa S; Motoashi Y
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):249-56. PubMed ID: 4807877
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of respiratory efforts on b2-agonist induced bronchodilation in mechanically ventilated COPD patients: a prospective clinical study.
    Malliotakis P; Mouloudi E; Prinianakis G; Kondili E; Georgopoulos D
    Respir Med; 2007 Feb; 101(2):300-7. PubMed ID: 16774821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pirbuterol.
    Crompton GK; Grant IW
    Lancet; 1984 Apr; 1(8380):795. PubMed ID: 6143112
    [No Abstract]   [Full Text] [Related]  

  • 35. Six month inhalation studies of pirbuterol acetate aerosol in the beagle dog and squirrel monkey.
    Levinsky HV; Breckenridge C; Lough R; Gonci DA; McIlhenny HM; Qureshi S
    Fundam Appl Toxicol; 1981; 1(6):426-31. PubMed ID: 7185594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microencapsulation of bitolterol for controlled release and its effect on bronchodilator and heart rate activities in dogs.
    John PM; Minatoya H; Rosenberg FJ
    J Pharm Sci; 1979 Apr; 68(4):475-81. PubMed ID: 438974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of a new bronchodilator agent, NAB 365, on the cyclic AMP level in the airway].
    Nomura T; Satake T
    Nihon Rinsho; 1976 Oct; 34(10):3099-103. PubMed ID: 187814
    [No Abstract]   [Full Text] [Related]  

  • 38. Selected ion monitoring assay for the bronchodilator pirbuterol.
    Falkner FC; McIlhenny HM
    Biomed Mass Spectrom; 1976 Oct; 3(5):207-11. PubMed ID: 974234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability of sublingual ergotamine.
    Tfelt-Hansen P; Paalzow L; Ibraheem JJ
    Br J Clin Pharmacol; 1982 Feb; 13(2):239-40. PubMed ID: 7059424
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
    Constantine JW; McIlhenny HM; Moore PF
    J Pharmacol Exp Ther; 1979 Mar; 208(3):371-6. PubMed ID: 430357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.